跳至主要内容
临床试验/ISRCTN10335153
ISRCTN10335153已完成未知

A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT).

Institut de Recherches Internationales Servier (France)0 个研究点目标入组 80 人开始时间: 2007年9月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Women of at least 50 years old
  • 2. Post-menopausal for at least 5 years
  • 3. Osteoporosis

排除标准

  • 1. Evolutive cancer during the past 5 years with a risk of bone metastases
  • 2. Body Mass Index less than 18 or greater than 30 kg/m^2
  • 3. Severe malabsorption

研究者

发起方
Institut de Recherches Internationales Servier (France)

相似试验

已完成
不适用
A double-blind, multicentric, multinational randomised study to assess the effects of one year administration of 2 g per day of strontium ranelate versus marketed bisphosphonates in women with postmenopausal osteoporosis on bone microarchitecture as measured by high-resolution peripheral-quantitative computed tomography (p-QCT)
ISRCTN82719233Institut de Recherches Internationales Servier (France)72
已完成
不适用
Cold oxygenated machine preservation of aged renal donation after cardiovascular death transplantsMachine perfusion preservation techniques of kidney graftsInjury, Occupational Diseases, Poisoning
ISRCTN32967929niversity of Oxford (UK)197
已完成
不适用
A double-blind, multicentre, international randomised study to assess the effects of 6 months or 12 months administration of strontium ranelate versus biphosphonates on bone remodelling and bone safety assessed by histomorphometry in women with postmenopausal osteoporosisPostmenopausal osteoporosis in womenMusculoskeletal DiseasesOsteoporosis
ISRCTN50493318Institut de Recherches Internationales Servier (France)387
已完成
2 期
A Phase II, Open-label, Randomized, Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell™ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)Ischemic cardiomyopathy
ISRCTN17181395Bioheart Inc. (USA)46
进行中(未招募)
不适用
Effects of strontium ranelate on bone quality before dental implantatioDental implantation in osteoporotic patients or in patients at risk of osteoporotic fractureMedDRA version: 14.1Level: PTClassification code 10064143Term: Dental implantationSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2011-002370-23-DEInstitut de Recherches Internationales Servier60